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Abstract
Background: Techniques for measuring protein abundance are rapidly advancing and we are now
in a situation where we anticipate many protein abundance data sets will be available in the near
future. Since proteins are translated from mRNAs, their expression is expected to be related to
their abundance, to some degree.
Results: We have developed a web tool, called PARE (Protein Abundance and mRNA Expression;
http://proteomics.gersteinlab.org), to correlate these two quantities. In addition to globally
comparing the quantities of protein and mRNA, PARE allows users to select subsets of proteins
for focused study (based on functional categories and complexes). Furthermore, it highlights
correlation outliers, which are potentially worth further examination.
Conclusion:  We anticipate PARE will facilitate comparative studies on mRNA and protein
abundance by the proteomics community.
Background
Quantifying mRNA expression is currently one of the
most exciting and active areas in genomics, and as a result
there are copious amounts of data available. However,
mRNA does not directly arbitrate biological function; that
role is filled by proteins, which are translated from mRNA
and connect mRNA to biological processes by acting on
the latter as a regulator. In contrast to the abundance of
mRNA expression data, considerably fewer quantitative
protein expression datasets are available due to the com-
paratively recent advent of methods for measuring protein
abundance on a large scale (such as the use of ICAT and
iTRAQ with mass spectrometry) and the difficulty of these
experiments relative to chip-based mRNA studies. Also,
for many studies, protein abundance data has not been
published and is not available via public databases.
Because protein levels are linked to mRNA expression by
the process of translation, we expect a relationship
between these abundances. Moreover, if a high correla-
tion is found, we can use mRNA expression data to
directly model protein expression. Conversely, a low cor-
relation indicates that the abundance of a particular pro-
tein is somewhat independent of mRNA expression.
Similar to the first-order kinetics theory of chemical reac-
tions, the theory governing the relation between mRNA
and protein considers the protein synthesis rate to be pro-
portional to the corresponding mRNA concentration and
the protein degradation rate to be proportional to protein
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concentration [1]. This relationship can be expressed in
the equation: d [P]i/dt = ks, i[mRNA]i-kd, i[P]i
where [P]i is the concentration of protein i, [mRNA]i is the
corresponding mRNA concentration, ks, i is the protein
synthesis rate constant, and kd, i is the overall protein deg-
radation and dilution rate constant [2-4]. Ideally, a time
series of protein abundance and corresponding mRNA
expression data could be used to verify the relationship in
the above equation, but such experiments are hard to
implement. However, at steady state, the change of pro-
tein abundance over time (the left side of the above equa-
tion) can be assumed to be zero, giving [P]i = (ks, i/kd, i)
[mRNA]i.
This equation suggests that a linear correlation between
protein abundance and mRNA expression level is
expected at steady state. To date, there have been a small
number of studies to correlate experimental mRNA
expression levels and protein abundance, mostly in
human cancer and yeast cells. For the most part, only lim-
ited correlations are reported [5-10]. These results suggest
that complicated post-transcriptional and/or post-transla-
tional mechanisms may be involved in determining final
protein abundance.
Note that in the equations, the rate constants ks, i and kd, i
vary by protein species. Thus, in addition to a global cor-
relation, a more reasonable analysis will focus on a given
protein species and study a time series of its abundance
with the corresponding mRNA expression, or focus on
members of a protein complex, which are likely to have
similar rate constants, at a steady state. Greenbaum et al.
found a significantly higher correlation for proteins with
high ribosomal occupancy (i.e., much of the expressed
mRNA in the cell is associated with ribosomes and there-
fore being translated) and high variability (associated
with highly controlled mRNA regulation), respectively
[9]. Furthermore, there might be a significant amount of
error and noise, intrinsic and extrinsic, in both protein
and mRNA experiments [11-13]. This problem is expected
to be alleviated by advances in experimental techniques
and improvements in data quality.
Implementation
We have developed a tool to conduct the aforementioned
studies on a large scale in order to advance our under-
standing of the relationship between protein and mRNA
expression. The package, named PARE, is implemented in
Perl/CGI on our website and available to the research
community [14]. The server operates on GNU/Linux 2.6,
and runs Apache 2.0.
The implementation of the web tool can be divided into
three parts: (a) selection of mRNA and protein abundance
data; (b) correlating mRNA and protein data for selected
subsets; and (c) identifying outliers from the trend. Each
of these parts is described in more detail below.
a. Selection of mRNA and protein abundance data
PARE requires as input quantitative mRNA and protein
abundance data. On our website, users can choose to
upload these datasets, select from pre-collected, currently
available datasets (Figure 1 of Supplementary Data), or
obtain datasets from external databases. Upon entering
the web tool, the user is directed to either select an organ-
ism to access the corresponding pre-collected datasets or
to upload datasets. We note that there are many mRNA
microarray datasets available at external databases,
including Symatlas [15], NCBI Gene Expression Omnibus
(GEO) [16,17], and Yale Protein Expression Database
(YPED). We provide links to these sites from PARE, and
are in the process of developing a direct interface for
accessing and analyzing YPED datasets.
The available pre-collected datasets include large-scale
yeast data [7,8,18-24], as well as a small amount of mam-
malian data. Relative quantitation datasets (i.e., expres-
sion or abundance ratios) are also included, and are
denoted on the site by 'REL'. These datasets are typically
correlated on a log-log scale. To date, we have included
only published datasets as those that are pre-collected.
A complete list of citations for the pre-collected datasets is
available online [14]. This table details the data type,
organism, number of ORFs for which data are available,
experimental method, whether the dataset is relative
(ratios) or absolute quantitation, and PubMed-linked
citations. We expect the collected data to increase consid-
erably in the future.
b. Correlating mRNA and protein data for selected subsets
An overall correlation between mRNA and protein is use-
ful to give a sense of the big picture, and users can choose
"correlate everything" to conduct this analysis. Users can
also perform the correlation for a subset of proteins
selected from MIPS [25] or Gene Ontology (GO) [26] cat-
egories, or upload a definition file to use a customized cat-
egorization. Once the user has selected subcategories for
analysis, MySQL is used to retrieve the corresponding
mRNA and protein data for correlation analysis. If a cate-
gorization analysis is chosen, the correlation from all the
selected categories will be shown, sorted by correlation
(default) or by category size (example output shown in
Figure 1). GNUplot is used to generate the correlation
plots. We also include the value for mutual information
computed from the mRNA expression and protein abun-
dance levels. This quantity will highlight relationships
between mRNA and protein that are not linear. (The
default number of bins used for the mutual informationBMC Bioinformatics 2007, 8:309 http://www.biomedcentral.com/1471-2105/8/309
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Example output from PARE for a categorization analysis Figure 1
Example output from PARE for a categorization analysis.BMC Bioinformatics 2007, 8:309 http://www.biomedcentral.com/1471-2105/8/309
Page 4 of 5
(page number not for citation purposes)
calculation is taken to be ten percent of the number of
matched pairs of mRNA and protein levels).
c. Identifying outliers from the trend
After the proteins of interest are specified by users, PARE
outputs the mRNA-protein scatter plot where the correla-
tion, fit line and its equation, and the top outliers will be
highlighted, as well as the combined mRNA-protein
abundance data sorted by the perpendicular distance of a
data point to the fit line. An example of the output is
shown in Figure 2 of the supplementary data [see Addi-
tional file 1]. A few options are available for user custom-
ization of the output. In some cases, such as when the data
are highly scattered, a log-log correlation will make more
sense than the default linear correlation, and users can
instruct PARE to toggle to a log-log plot. Additionally, the
user can customize the number of the outliers shown (the
default number is 5) by absolute number or relative per-
centage.
Results and discussion
PARE provides a rapid means of quickly assessing correla-
tions in quantitative proteomics data for matched experi-
mental mRNA and protein abundance datasets. It cannot
be overemphasized that the quality of the correlations
obtained is dependent upon appropriate selection of cor-
responding mRNA expression and protein abundance
datasets. The user bears the responsibility of determining
whether the experimental conditions for uploaded mRNA
and protein datasets are sufficiently analogous to merit
correlation. Another aspect for users to consider when
reviewing datasets is any pre-processing steps that
occurred between data collection and tabulation of quan-
titative expression or abundance values or ratios.
In biological systems, there are clearly many factors that
may influence the correlation between mRNA expression
and protein abundance. Protein synthesis and degrada-
tion rates, post-transcriptional mRNA regulation, and
even experimental noise can affect the results. The correla-
tion analysis provided by PARE allows us to identify tar-
gets for more detailed study to further the development of
new models.
A key feature of our tool is the ability to perform the cor-
relation analysis for selected subcategories (and groupings
thereof) of data. The correlations for different GO catego-
ries can, in fact, be dramatically different (see Table 1,
Supplementary Data). As discussed in the Introduction,
this analysis will provide an insight into how closely-con-
nected proteins are co-translated.
The correlation outliers are key targets for further experi-
mental studies. Tracing the expression and translation
processes of the outliers in detail should lead us to an
understanding of why they do not correlate well (perhaps
because of slow protein degradation for particular pro-
teins) and the underlying biological processes involved.
Conclusion
We have developed a web tool, PARE, to analyze protein
abundance and mRNA expression data. The utility of the
correlations provided by PARE will improve as the quality
of available data sets increases and the methodologies for
determining protein abundance are refined. For instance,
current protein abundance data are deduced from the
intensity of gel spots or the measurement of identified
peptides from enzymatic digests, yet Ishihama et al. shows
that emPAI (exponentially modified protein abundance
index) may be a better parameter to use [27]. We antici-
pate PARE will facilitate comparative studies on mRNA
and protein abundance by the proteomics community.
Availability
Project name: PARE
Project home page: http://proteomics.gersteinlab.org
Contact: proteomics@bioinfo.mbb.yale.edu
Operating systems: Platform independent
Programming language: Perl/CGI
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